Drug profile · INN
idarubicin
ZAVEDOS SOLUTION
idarubicin (ZAVEDOS SOLUTION) is a dna topoisomerase ii alpha inhibitor. Associated with Pfizer Australia Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 16
News articles 0
Drug details — idarubicin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 16
- Data quality
- 0.81
Quick answer
idarubicin (ZAVEDOS SOLUTION) is a dna topoisomerase ii alpha inhibitor. Associated with Pfizer Australia Pty Ltd.
Key facts
INN idarubicin
Brand ZAVEDOS SOLUTION
Mechanism DNA topoisomerase II alpha inhibitor
Originator Pfizer Australia Pty Ltd
Mechanism of action
DNA topoisomerase II alpha inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is idarubicin?
idarubicin (ZAVEDOS SOLUTION) is a dna topoisomerase ii alpha inhibitor. Associated with Pfizer Australia Pty Ltd.
What is the brand name for idarubicin?
ZAVEDOS SOLUTION is a marketed brand name for idarubicin. Check FDA Drugs@FDA for the current US label holder and prescribing information.